TABLE 1.
Description of plasmids constructed for this study
| Plasmid | EBV nucleotides |
|---|---|
| pHEBo-1.1Δ9138-9516 | 7333–9137 |
| pHEBo-1.1Δ9138-9459 | 7333–9137; 9460–9516 |
| pHEBo-1.1Δ9138-9459+M13 | 7333–9137; 9460–9516a |
| pHEBo-2.2 | 7333–8995 |
| pHEBo-2.2.1 | 7333–9137b |
| pHEBo-2.2.5 | 7333–8995; 9019–9085 |
| pHEBo-2.2.6 | 7333–8995; 9033–9069 |
| pHEBo-2.2.7 | 7333–8995; 9019–9069 |
| pHEBo-2.2.8 | 7333–8995; 9033–9085 |
| pHEBo-2.2.20 | 7333–8995; 9033–9123 |
| pHEBo-2.2.24 | 7333–9085 |
| pBS/FR | 7333–8994 |
| pBS/FR.DS | 7333–9137 |
a
Contains nt 6252 to 6935 from M13mp18 between EBV nt 7333 to 9137 and 9560 to 9516.
b
Contains base pair transversions at the −5 and +5 positions of EBNA-1 binding sites 1 and 2.